We went blind after using weight-loss drugs like Ozempic and Mounjaro
Ozempic and other diabetes drugs used for weight loss are leaving some users blind or with vision impairment.
When James Norris, a 56-year-old mechanic from Roxbury, New Jersey, went on a low dose of Mounjaro, a GLP-1 medication similar to Ozempic, to lose weight in March 2023, he thought it would be a miracle drug.
At 289 pounds, he had struggled to lose weight for years with diet and exercise. His wife had lost 60 pounds in several months on the medication, and her success convinced him to give it a shot.
“I just couldn’t keep weight off — [the drug] seemed like a good alternative,” he said.